Cigna Group (NYSE:CI - Free Report) - Research analysts at Leerink Partnrs dropped their Q3 2025 EPS estimates for shares of Cigna Group in a research report issued on Thursday, July 31st. Leerink Partnrs analyst W. Mayo now expects that the health services provider will post earnings per share of $7.48 for the quarter, down from their prior forecast of $7.97. The consensus estimate for Cigna Group's current full-year earnings is $29.77 per share. Leerink Partnrs also issued estimates for Cigna Group's Q1 2026 earnings at $8.00 EPS, Q2 2026 earnings at $7.95 EPS, Q3 2026 earnings at $8.19 EPS, FY2027 earnings at $37.63 EPS and FY2029 earnings at $47.70 EPS.
Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, beating analysts' consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. During the same period last year, the firm posted $6.72 EPS. Cigna Group's quarterly revenue was up 11.0% on a year-over-year basis.
Several other equities research analysts have also commented on the stock. Barclays decreased their target price on shares of Cigna Group from $385.00 to $354.00 and set an "overweight" rating on the stock in a research report on Friday. Cowen restated a "buy" rating on shares of Cigna Group in a research report on Monday, May 5th. Royal Bank Of Canada restated an "outperform" rating and set a $371.00 target price on shares of Cigna Group in a research report on Thursday, June 26th. Mizuho boosted their target price on shares of Cigna Group from $360.00 to $384.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Finally, TD Cowen upgraded shares of Cigna Group to a "strong-buy" rating in a research report on Monday, June 23rd. Three analysts have rated the stock with a hold rating, sixteen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $378.67.
Get Our Latest Stock Report on Cigna Group
Cigna Group Stock Performance
NYSE:CI opened at $262.26 on Monday. The firm's fifty day moving average price is $308.90 and its 200 day moving average price is $312.33. Cigna Group has a 1-year low of $256.89 and a 1-year high of $370.83. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The firm has a market cap of $70.01 billion, a price-to-earnings ratio of 14.32, a price-to-earnings-growth ratio of 0.79 and a beta of 0.47.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. Flaharty Asset Management LLC acquired a new position in Cigna Group in the 1st quarter valued at about $28,000. 1248 Management LLC acquired a new position in Cigna Group in the 1st quarter valued at about $29,000. Solstein Capital LLC acquired a new position in Cigna Group in the 2nd quarter valued at about $29,000. Activest Wealth Management raised its stake in Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock valued at $30,000 after purchasing an additional 72 shares during the last quarter. Finally, Chilton Capital Management LLC acquired a new position in Cigna Group in the 2nd quarter valued at about $30,000. Institutional investors and hedge funds own 86.99% of the company's stock.
Cigna Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, September 18th. Investors of record on Thursday, September 4th will be paid a $1.51 dividend. The ex-dividend date of this dividend is Thursday, September 4th. This represents a $6.04 annualized dividend and a yield of 2.3%. Cigna Group's payout ratio is presently 32.97%.
Cigna Group Company Profile
(
Get Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.